Patents by Inventor Harshavardhana Reddy Mallipalli

Harshavardhana Reddy Mallipalli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11295857
    Abstract: A connected health system includes an instant user feedback interface that captures meaningful feedback from medical patients, such as dialysis patients, when they are most apt to provide it. The system enables a patient to speak freely with comments or questions about their dialysis experience at the time that the comments or questions arise. Accordingly, the system described herein facilitates and invites the providing of user feedback by voice input, along with relevant treatment and system status information, in a secure way to improve user experience and to help in machine development using simple and easily accessible interface buttons. By providing a conduit for instant user feedback, that may be provided along with relevant treatment and/or system status information that has caused the user feedback, the system described herein may improve the way the patient feels about interactions with the company and their dialysis machines and services.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: April 5, 2022
    Assignees: Fresenius Medical Care Deutschland GmbH, Fresenius Medical Care Holdings, Inc.
    Inventors: David Yuds, Manuel Hassler, Jessica Steuber, Harshavardhana Reddy Mallipalli
  • Patent number: 11173237
    Abstract: A spectroscopic detection system includes a sensor configured to reflect light of a first wavelength associated with a presence of a reference substance on the sensor and configured to reflect light of a second wavelength associated with a presence of a monitored substance on the sensor, wherein the monitored substance flows to the sensor from a circulating fluid. The spectroscopic detection system further includes a detector that has first and second channels for respectively receiving the light of the first and second wavelengths reflected from the sensor and one or more processors in electrical communication with the detector and configured to identify an excess condition of the monitored substance with respect to the circulating fluid based on a ratio of a second amount of the light of the second wavelength received at the detector to a first amount of the light of the first wavelength received at the detector.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: November 16, 2021
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Harshavardhana Reddy Mallipalli, Philip Scott James, Ethan Lee Zimbra, Kerissa Adams, Troy Dayton, Jon F. Moss
  • Publication number: 20200405937
    Abstract: A spectroscopic detection system includes a sensor configured to reflect light of a first wavelength associated with a presence of a reference substance on the sensor and configured to reflect light of a second wavelength associated with a presence of a monitored substance on the sensor, wherein the monitored substance flows to the sensor from a circulating fluid. The spectroscopic detection system further includes a detector that has first and second channels for respectively receiving the light of the first and second wavelengths reflected from the sensor and one or more processors in electrical communication with the detector and configured to identify an excess condition of the monitored substance with respect to the circulating fluid based on a ratio of a second amount of the light of the second wavelength received at the detector to a first amount of the light of the first wavelength received at the detector.
    Type: Application
    Filed: July 31, 2020
    Publication date: December 31, 2020
    Inventors: Harshavardhana Reddy Mallipalli, Philip Scott James, Ethan Lee Zimbra, Kerissa Adams, Troy Dayton, Jon F. Moss
  • Patent number: 10765793
    Abstract: A spectroscopic detection system includes a sensor configured to reflect light of a first wavelength associated with a presence of a reference substance on the sensor and configured to reflect light of a second wavelength associated with a presence of a monitored substance on the sensor, wherein the monitored substance flows to the sensor from a circulating fluid. The spectroscopic detection system further includes a detector that has first and second channels for respectively receiving the light of the first and second wavelengths reflected from the sensor and one or more processors in electrical communication with the detector and configured to identify an excess condition of the monitored substance with respect to the circulating fluid based on a ratio of a second amount of the light of the second wavelength received at the detector to a first amount of the light of the first wavelength received at the detector.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: September 8, 2020
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Harshavardhana Reddy Mallipalli, Philip Scott James, Ethan Lee Zimbra, Kerissa Adams, Troy Dayton, Jon F. Moss
  • Publication number: 20200040323
    Abstract: Methods for purifying urease are described that make use of a precipitating agent such as ammonium sulfate to obtain urease as a precipitate. The method can involve use of a solubilizing agent, such as a citrate-containing solution, to dissolve the precipitate. The method can involve the use of a sugar to provide protected urease in a sugar-urease solution and immobilization of the urease. The method can involve freeze drying of the immobilized urease. A sugar-urease preparation and an immobilized urease, and a sorbent cartridge containing the urease are described as well as methods to conduct dialysis.
    Type: Application
    Filed: July 31, 2018
    Publication date: February 6, 2020
    Inventors: Jun Yi, Harshavardhana Reddy Mallipalli